World Health Organization Surveys of Transmitted and Acquired HIV Drug Resistance in Resource Limited Settings CROI 2011 S Bertagnolio*, K Kelley*, A Saadani.
Expanding HIV testing and the use of ARVs for treatment and prevention Getting to 15 million by 2015… and thinking beyond Gottfried Hirnschall MD, MPH.
...visualizing classifier performance in R Tobias Sing, Ph.D. (joint work with Oliver Sander) Modeling & Simulation Novartis Pharma AG 3 rd BaselR meeting.
Recombinant Origin of the Retrovirus XMRV
mlearning for Health Care Workers in Low Resource Settings
Superbugs and the Role of Diagnostics Explained
Superbugs and the role of diagnostics explained
TIM-family Proteins Inhibit HIV-1 Release
Individual level Early warning indicators for Virological failure (independent of adherence) KZN STUDY –UPDATE South African ART Resistance Cohort Studies.
Overview of HIV Disease Dr. Marianne Harris AIDS Research Program St. Paul’s Hospital.
HIV Drug Resistance Control: the Latin American experience Giovanni Ravasi Pan-American Health Organization, Brazil [email protected] International AIDS.
Predictors of Virologic Failure and HIV Drug Resistance Among Patients Receiving Fixed Dose Combination Stavudine/Lamivudine/Nevirapine in Northern Tanzania.